Dicerna Pharmaceuticals CEO Douglas Fambrough's 2020 pay jumps 31% to $6.6M
Dicerna Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 20, 2021
Dicerna Pharmaceuticals reported fiscal year 2020 executive compensation information on April 20, 2021.
In 2020, seven executives at Dicerna Pharmaceuticals received on average a compensation package of $3.8M, a 27% increase compared to previous year.
Average pay of disclosed executives at Dicerna Pharmaceuticals
Douglas M. Fambrough, III, Chief Executive Officer, received $6.6M in total, which increased by 31% compared to 2019. 59% of Fambrough's compensation, or $3.9M, was in option awards. Fambrough also received $345K in non-equity incentive plan, $575K in salary, $1.8M in stock awards, as well as $19K in other compensation.
For fiscal year 2020, the median employee pay was $311,375 at Dicerna Pharmaceuticals. Therefore, the ratio of Douglas M. Fambrough, III's pay to the median employee pay was 21 to one.
Ralf Rosskamp, Chief Medical Officer, received a compensation package of $4.3M, which increased by 100% compared to previous year. 61% of the compensation package, or $2.6M, was in option awards.
John B. Green, Chief Financial Officer, earned $4M in 2020, a 92% increase compared to previous year.
Bob D. Brown, Chief Scientific Officer, received $3.4M in 2020, which increases by 57% compared to 2019.
James B. Weissman, Chief Operating Officer, earned $3.3M in 2020.
Shreeram Aradhye, Chief Medical Officer, received $2.5M in 2020.
Douglas W. Pagán, Chief Financial Officer, earned $2.4M in 2020.
Related executives
Douglas Fambrough
Dicerna Pharmaceuticals
Chief Executive Officer
Douglas Pagán
Dicerna Pharmaceuticals
Chief Financial Officer
John Green
Dicerna Pharmaceuticals
Chief Financial Officer
Shreeram Aradhye
Dicerna Pharmaceuticals
Chief Medical Officer
Bob Brown
Dicerna Pharmaceuticals
Chief Scientific Officer
James Weissman
Dicerna Pharmaceuticals
Chief Operating Officer
Ralf Rosskamp
Dicerna Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on April 20, 2021.